Poniard Pharmaceuticals, Inc. (PARD) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Poniard Pharmaceuticals, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-0.79
Burn Risk
P/B Ratio
2.88
Strong
WeakModerateStrong
Earnings Yield
-123.33%
Yield Gap
Profitability Health
2010Return on Equity
-355.51%
Weak
WeakModerateStrong
Operating Margin
-
No data
Net Profit Margin
-
No data
Growth Indicators
2010Revenue Growth
-
No data
Net Income Growth
34.26%
Strong
WeakModerateStrong
EPS Growth
49.62%
Strong
WeakModerateStrong
Efficiency & Liquidity
2010Current Ratio
3.23
Strong
WeakModerateStrong
Quick Ratio
3.23
Strong
WeakModerateStrong
Asset Turnover
-
No data
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-99.65%
Weak
WeakModerateStrong
EV / Free Cash Flow
-1.02x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.01x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
-
No data
Return on Invested Capital
-
No data
Cash Conversion Cycle
0.00 days
Strong
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for PARD.
View Financial Statements